LAVA Therapeutics N.V.
LVTX
$1.54
$0.0251.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 56.17M | 66.56M | 76.58M | 78.88M | 86.80M |
| Total Receivables | -- | -- | -- | 1.03M | 1.15M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.92M | 1.56M | 1.07M | 1.63M | 2.22M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.40M | 1.66M | 1.65M | -- | -- |
| Total Current Assets | 60.50M | 69.78M | 79.30M | 81.54M | 90.17M |
|
|
|||||
| Total Current Assets | 60.50M | 69.78M | 79.30M | 81.54M | 90.17M |
| Net Property, Plant & Equipment | 43.00K | 1.28M | 1.44M | 1.71M | 1.97M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.00K | 95.00K | 91.00K | 114.00K | 144.00K |
| Total Assets | 60.55M | 71.16M | 80.83M | 83.36M | 92.28M |
|
|
|||||
| Total Accounts Payable | 1.43M | 1.52M | 2.72M | 2.82M | 4.16M |
| Total Accrued Expenses | 3.47M | 6.88M | 9.13M | 6.26M | 4.08M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 306.00K | 5.20M | 6.13M | 5.87M |
| Total Finance Division Other Current Liabilities | 715.00K | 1.66M | 949.00K | -- | -- |
| Total Other Current Liabilities | 715.00K | 1.66M | 949.00K | -- | -- |
| Total Current Liabilities | 5.61M | 10.37M | 18.01M | 15.20M | 14.11M |
|
|
|||||
| Total Current Liabilities | 5.61M | 10.37M | 18.01M | 15.20M | 14.11M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 6.00K | 80.00K | 164.00K | 295.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 35.00M | 35.00M | 35.00M | 35.00M | 35.00M |
| Total Liabilities | 40.61M | 45.37M | 53.09M | 50.36M | 49.41M |
|
|
|||||
| Common Stock & APIC | 216.35M | 215.91M | 215.37M | 198.17M | 198.16M |
| Retained Earnings | -187.09M | -178.45M | -174.97M | -168.93M | -156.72M |
| Treasury Stock & Other | -9.33M | -11.68M | -12.66M | 3.76M | 1.44M |
| Total Common Equity | 19.94M | 25.78M | 27.75M | 32.99M | 42.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.94M | 25.78M | 27.75M | 32.99M | 42.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.94M | 25.78M | 27.75M | 32.99M | 42.88M |
|
|
|||||